These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. Buzás György M; Székely E; Illyés G; Széles I Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194 [TBL] [Abstract][Full Text] [Related]
7. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics. Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591 [TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. Laine L; Estrada R; Trujillo M; Emami S Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755 [TBL] [Abstract][Full Text] [Related]
9. [Ranitidine-bismuth citrate versus omeprazole plus two antibiotics for seven days for the eradication of Helicobacter pylori: a non-concluding clinical essay]. Cuena Boy R An Med Interna; 2002 Aug; 19(8):439-40; author reply 440. PubMed ID: 12244799 [No Abstract] [Full Text] [Related]
10. Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori. Dixon JS; Pipkin GA; Mills JG; Wood JR J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():47-58. PubMed ID: 9440055 [TBL] [Abstract][Full Text] [Related]
11. New developments in Helicobacter pylori eradication therapy. Pounder RE Scand J Gastroenterol Suppl; 1997; 223():43-5. PubMed ID: 9200305 [TBL] [Abstract][Full Text] [Related]
12. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. de Boer WA; Haeck PW; Otten MH; Mulder CJ Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338 [TBL] [Abstract][Full Text] [Related]
13. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. Scheen AJ Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183 [TBL] [Abstract][Full Text] [Related]
14. Optimal strategy of treatment of Helicobacter pylori infection: renaissance of antisecretory drugs? Nijevitch AA; Farztdinov KM; Sataev VU; Dashkova S; Kazykhanov NS Am J Gastroenterol; 2001 Mar; 96(3):921-2. PubMed ID: 11280584 [No Abstract] [Full Text] [Related]
15. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042 [TBL] [Abstract][Full Text] [Related]
17. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy. Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317 [TBL] [Abstract][Full Text] [Related]
18. What is the most effective regimen for eradication of Helicobacter pylori in patients who have failed a first eradication attempt? Markova T; Schwartz K J Fam Pract; 2002 Jan; 51(1):14. PubMed ID: 11927054 [No Abstract] [Full Text] [Related]
19. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Bardhan KD; Dekkers CP; Lam SK; Nowak A; Schaffalitzky de Muckadell OB; Schutze K; Tildesley G; Kler L; Forster JK; Lacey LF Aliment Pharmacol Ther; 1995 Oct; 9(5):497-506. PubMed ID: 8580269 [TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole. Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]